NCT00154076

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Eisai Korea Inc. · Industry
• Sex: All
• Age: 13 Years
• Healthy volunteers: Not accepted

Summary

To assess the efficacy and safety of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Conditions

• Epilepsy

Interventions

Type	Name	Description
DRUG	Zonisamide	Initial dose is 100mg/day, increase after 2 weeks to 200mg/day. The maximum dose is 600mg/day.
DRUG	Topiramate	Initial dose is 25mg/day, increase every 1 week to 100mg/day. The maximum dose is 400mg/day.

Timeline

• Start date: 2005-09-01
• Primary completion: 2008-08-01
• Completion: 2008-12-01
• First posted: 2005-09-12
• Last updated: 2009-09-02

Locations

1 site across 1 country: South Korea